Leptin acts on specific populations of hypothalamic neurons to regulate feeding behavior, energy expenditure, and neuroendocrine function. It is not known, however, whether the same neural circuits mediate leptin action across its full biologic dose-response curve, which extends over a broad range, from low levels seen during starvation to high levels characteristic of obesity. Here, we show that the characteristic fall in leptin with fasting causes a rise in neuropeptide Y (NPY) messenger RNA (mRNA), as well as a fall in POMC and cocaine and amphetamine-regulated transcript (CART) mRNAs. Sc infusion of leptin sufficient to maintain plasma levels within the physiologic range during the fast prevents changes in the expression of these peptides, as well as changes in neuroendocrine function, demonstrating that multiple neural circuits are highly sensitive to small changes in leptin within its low physiologic range. In contrast, a modest elevation of plasma leptin above the normal fed range by constant sc infusion, which produced marked reduction in food intake and body weight, decreased NPY mRNA in the arcuate hypothalamic nucleus but did not affect the levels of mRNAs encoding the anorexigenic peptides ␣-MSH, CART or CRH. These results suggest that the dose response characteristics of leptin on hypothalamic target neurons at the level of mRNA expression are variable, with some neurons (e.g. NPY) responding across a broad dose range and others (e.g. POMC and CART) showing a limited response within the low range. These results further suggest that the central targets of leptin that mediate the transition from starvation to the fed state may be distinct from those that mediate the response to overfeeding and obesity. (Endocrinology 140: [4923][4924][4925][4926][4927][4928][4929][4930][4931] 1999) L EPTIN PLAYS A major role in energy homeostasis. Rising leptin levels are proposed to limit weight gain through inhibition of food intake and increased thermogenesis (reviewed in Refs. 1-3). A second aspect of leptin action occurs as levels fall with starvation, triggering metabolic and neuroendocrine responses that decrease energy expenditure and promote feeding behavior (1-4). Leptin is thought to influence both of these aspects of energy homeostasis mainly by regulating the expression of hypothalamic neuropeptides, which then influence feeding behavior, autonomic, and neuroendocrine function (1, 2). These hypothalamic targets fall into two major groups: anabolic peptides that are inhibited by leptin, and catabolic peptides that are stimulated by leptin. For example, levels of the orexigenic peptide neuropeptide Y (NPY) are increased in the hypothalamus as a result of leptin deficiency in ob/ob mice and starvation, and this overexpression is decreased by leptin administration (2, 4, 5). The results of genetic crosses reveal that NPY is partially responsible for hyperphagia, impaired thermoregulation, and neuroendocrine abnormalities in ob/ob mice (6). The levels of three anorectic peptides [␣-MSH (a product of the POMC gene), CRH, and cocaine and amphetamine-regulated peptide (CART)] are each decreased by leptin deficiency in ob/ob mice and starvation, and increased after leptin treatment (2, 7-9). The anorexigenic effect of leptin may therefore be mediated by stimulation of ␣-MSH, CRH, and CART (2, 7-9), as well as inhibition of NPY (2, 4).
L EPTIN PLAYS A major role in energy homeostasis. Rising leptin levels are proposed to limit weight gain through inhibition of food intake and increased thermogenesis (reviewed in Refs. [1] [2] [3] . A second aspect of leptin action occurs as levels fall with starvation, triggering metabolic and neuroendocrine responses that decrease energy expenditure and promote feeding behavior (1) (2) (3) (4) . Leptin is thought to influence both of these aspects of energy homeostasis mainly by regulating the expression of hypothalamic neuropeptides, which then influence feeding behavior, autonomic, and neuroendocrine function (1, 2) . These hypothalamic targets fall into two major groups: anabolic peptides that are inhibited by leptin, and catabolic peptides that are stimulated by leptin. For example, levels of the orexigenic peptide neuropeptide Y (NPY) are increased in the hypothalamus as a result of leptin deficiency in ob/ob mice and starvation, and this overexpression is decreased by leptin administration (2, 4, 5) . The results of genetic crosses reveal that NPY is partially responsible for hyperphagia, impaired thermoregulation, and neuroendocrine abnormalities in ob/ob mice (6) . The levels of three anorectic peptides [␣-MSH (a product of the POMC gene), CRH, and cocaine and amphetamine-regulated peptide (CART)] are each decreased by leptin deficiency in ob/ob mice and starvation, and increased after leptin treatment (2, (7) (8) (9) . The anorexigenic effect of leptin may therefore be mediated by stimulation of ␣-MSH, CRH, and CART (2, (7) (8) (9) , as well as inhibition of NPY (2, 4) .
Although the above findings have provided insights into potential mechanisms of leptin action in the brain, most studies have been carried out in rodents with total leptin deficiency or insensitivity, or have involved treatment with supraphysiologic doses of leptin. Consequently, it is not known which hypothalamic neurons and which physiologic pathways respond to alterations in leptin levels across its dose-response range, i.e. from low levels during fasting, to elevated levels in the fed state, and to even higher levels characteristic of obesity. To identify hypothalamic targets of leptin in two of these distinct phases of its physiologic doseresponse range, we examined the expression of hypothalamic neuropeptides and an array of physiologic effects in two paradigms. The first, which was intended to mimic the rise in leptin above the normal range, as would occur with overfeeding and early obesity, involved constant sc leptin infusion to ad libitum (ad lib)-fed rats. The second, which was designed to examine the effect of leptin on the adaptation to fasting, involved fasting with or without constant sc leptin infusion, such that the characteristic fall in leptin levels with fasting was prevented.
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Leptin infusion in ad lib-fed rats
Food intake and body weight were measured during the light and dark cycles on 3 consecutive days in three groups of rats (n ϭ 5/group). Blood was obtained by tail bleeding within 1 min of handling, during the light (0800 -1000 h) and dark (1800 -2000 h) cycles, for measurement of leptin and corticosterone. Preliminary studies showed that plasma corticosterone levels were not inappropriately elevated when blood was obtained by this technique from rats acclimatized to daily handling (data not shown). The rats were anesthesized with methoxyfluorane (Metofane, Schering Plough, Union, NJ); and osmotic pumps (model 2ML2; Alza Corp., Palo Alto, CA), filled aseptically with recombinant murine leptin (Eli Lilly & Co., Indianapolis, IN) or PBS (pH 7.4) were implanted sc. Leptin was infused at a rate of 2 g/h or 4 g/h in two groups of rats (n ϭ 5/group), and food intake and body weight were monitored on alternate days. Control rats were infused with PBS. Blood was obtained by tail bleeding, on days 7 and 14 of leptin or saline infusion, for measurement of leptin and corticosterone.
After the period of leptin or saline infusion, the rats were anesthesized with sodium pentobarbital (50 g/kg BW ip) at 1600 -1800 h of the light cycle. Blood was obtained, via cardiac puncture, for hormone measurement; and the rats were perfused with diethylpyrocarbonate-treated PBS followed by 10% neutral buffered formalin. Brains were dissected, immersed in the same fixative overnight, cryoprotected with 20% sucrose-PBS, and stored at Ϫ80 C until processing. Frozen 30-m coronal sections were cut on a sliding microtome and processed for detection of messenger RNAs (mRNAs) for NPY, CRH, POMC, CART, i.e. peptides implicated in leptin action (2, (7) (8) (9) , and the long form leptin receptor (OBRb) by in situ hybridization histochemistry, as described previously (10 -12) .
Leptin infusion in fasted rats
Six groups of male Sprague Dawley rats (n ϭ 5/group) were housed and fed ad lib, as described above. Alzet miniosmotic pumps (model 2ML1) containing murine leptin (4 g/h) were implanted sc in two groups of rats. The others received PBS infusion. The choice of pumps was designed to infuse leptin or PBS for a total duration of 7 days. Starting from day 4 (after pump implantation), one group each of leptin and PBS-treated rats (n ϭ 5/group) were deprived of food for approximately 70 h (initiated at lights off at 1800 h). The rats were anesthesized with ip sodium pentobarbital injection on day 7 (1600 -1800 h). A control group of PBS-treated rats was allowed ad lib access to food throughout the infusion period. After obtaining blood by cardiac puncture, for hormone measurements, the rats were perfused, and brains were processed for detection of mRNA for neuropeptide, as described above.
Another group of leptin-and PBS-treated rats (n ϭ 5/group) was deprived of food for 70 h, as described above, and was allowed ad lib access to chow after the period of fasting (and PBS or leptin infusion). Food intake and body weight were measured daily for 3 days. Daily blood samples were obtained during the refeeding period, by tail incision, for leptin measurement. A control group of rats (n ϭ 5) received PBS infusion and was fed ad lib throughout the duration of the experiment.
Hormone measurements
Plasma hormones were measured by RIA using kits for leptin and insulin (Linco Research, Inc., St. Charles, MO), corticosterone and T 4 (ICN Biomedicals, Inc., Costa Mesa, CA), and testosterone (DPC, Los Angeles, CA), as described previously (4, 13) . Leptin was measured in duplicate 10-l plasma samples, obtained from tail bleeds or cardiac puncture, in one half of the reaction volume recommended by the manufacturer. The detection limit of leptin was 0.5 ng/ml; intraassay variation (cv), 4.2%; and interassay cv, 3.8%. Corticosterone was measured in duplicate 5-l samples obtained by tail bleeding or cardiac puncture; detection limit, 25 ng/ml; intraassay cv, 5.4%; and interassay cv, 4.8%. Insulin, T 4 , and testosterone were measured on duplicate plasma samples (100 l, 10 l, and 100 l, respectively) obtained by cardiac puncture. The detection limits and intraassay and interassay variations were as follows: insulin ϭ 0.1 ng/ml, 4.2%, and 5.3%); T 4 ϭ 0.5 g/dl, 4.6%, and 4.3%; and testosterone ϭ 0.2 ng/ml, 4.5%, and 6.5%, respectively. The effects of leptin and PBS infusion on the hormone concentrations among various treatment groups were compared by ANOVA and Fisher protected least-significant difference (PSLD) test (Statview 512, Abacus, Berkley, CA). Differences between nocturnal and diurnal leptin and corticosterone leptin levels were compared by twotailed t test. P Ͻ 0.05 was considered significant.
Image analysis
Brain sections from various treatment groups in each experiment were processed for in situ hybridization under the same conditions (10 -12) . After posthybridization washing and air drying, brain sections from leptin-or saline-treated rats in each experiment were matched and exposed to film (Biomax MR, Eastman Kodak Co., Rochester, NY) under the same conditions. The relative levels of NPY, POMC, CART, CRH, and OBRb mRNA in the hypothalamus were analyzed on film autoradiograms by laser densitometry using ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA). Autoradiograms from 4 rats in each treatment group were analyzed. The number of sections analyzed per region in each rat and the approximate levels (figures) in the atlas of Paxinos and Watson (14) . At each rostrocaudal level, a rectangle was drawn to enclose the nucleus of interest in a particular brain region, and the absorbance of the autoradiographic signal was measured. The rectangle was then reproduced to the same dimension and used to measure absorbances in similar regions in matched sections from other rats. Absorbance values corresponding to the content of neuropeptide mRNA per region were corrected for background (nonspecific signal) by subtracting the absorbance in a region on the same brain section not known to express that product. Statistical comparisons of integrated densities per brain region among various treatment groups was performed by ANOVA and Fisher PSLD test (Statview 512, Abacus). P Ͻ 0.05 was considered significant.
Brain sections were dipped in photographic emulsion and processed for microscopy (10, 11) . The slides were examined under bright-and darkfield optics with a Carl Zeiss Axioplan light microscope. Photomicrographs were produced by capturing images with a Kodak digital camera (Eastman Kodak Co.) mounted directly on the microscope and an Apple Macintosh Power PC computer, and combined into plates using Adobe Photoshop software. Figures were printed on an Eastman Kodak Co. 8650 dye sublimation printer.
Results

Leptin infusion in fed rats
Metabolic and neuroendocrine effects. There was a dose-related increase in plasma leptin in ad lib-fed rats in response to constant sc leptin infusion (Fig. 1 , A-C). Plasma leptin increased 1.5-to 2-fold within 1 week of constant sc leptin infusion and remained elevated thereafter. In addition to mean leptin levels being elevated, the infusion protocol prevented the diurnal variation in leptin levels ( Fig. 1) . Plasma corticosterone levels were 52% higher during the dark cycle than the light cycle (P Ͻ 0.05) in ad lib-fed rats infused with PBS (Table 1 ). In contrast, chronic leptin infusion at rates of 2 g/h and 4 g/h attenuated the nocturnal rise in corticosterone (Table 1) . Leptin infusion did not affect the levels of insulin, T 4 , or testosterone (Table 1) .
Body weight gain was not affected significantly within the first 3 days of leptin infusion, but it decreased thereafter ( Fig.  2A) . A dose effect of leptin to reduce weight gain was observed after 8 days of infusion and persisted through the duration of the experiment (Fig. 2A) . Nocturnal food intake was decreased by leptin after 3 days (P Ͻ 0.05) (Fig. 2B ). There was a dose effect of leptin to reduce nocturnal feeding after 7-9 days; however, unlike body weight, the additional reduction in nocturnal food intake in response to the higher leptin dose was gone after 10 days (Fig. 2B) . Nocturnal food intake was reduced by 25% in response to both 2 g/h and 4 g/h leptin at the end of the infusion period (Fig. 2B) . Chronic elevation of plasma leptin did not affect food intake during the light cycle (data not shown).
Effects on hypothalamic neuropeptide mRNA expression. The effect of leptin infusion on the expression of hypothalamic peptides implicated in leptin's effects on feeding behavior and the neuroendocrine axis was analyzed by in situ hybridization histochemistry. Constant sc leptin infusion at a rates of 2 g/h and 4 g/h resulted in significant reduction in NPY mRNA in the arcuate hypothalamus, by 25-50% (Figs. 3, A-C; and 4). On the other hand, leptin infusion did not affect the expression of CRH, POMC, and CART mRNA (Fig.  4) . There was no significant alteration in the level of OBRb mRNA in the hypothalamus in response to chronic leptin infusion in fed rats (data not shown).
Leptin infusion in fasted rats
Metabolic and neuroendocrine effects. To determine the effect of leptin on the response to fasting, rats were deprived of food for approximately 70 h, starting from day 4 after initiating leptin or PBS infusion. Leptin did not affect body weight or food intake during the prefast period (data not shown). There was a reduction in body weight by 16%, in response to fasting (Table 2) . Leptin infusion prevented the fall in plasma leptin that accompanies fasting but did not result in a further decrease in body weight (Table 2) . Fasting caused marked decreases in insulin (50%), T 4 (46%), and testosterone (74%) ( Table 2) . Maintenance of plasma leptin levels during fasting prevented the fall in T 4 and testosterone but did not affect the fall in insulin (Table 2) . Plasma corticosterone increased 3-fold, from 268 ng/ml to 815 ng/ml, in response to fasting, and it was not significantly affected by leptin treatment (Table 2 ). Figure 5 illustrates the changes in food intake, body weight, and plasma leptin in response to ad lib feeding during the postfast period. There was significant attenuation of weight gain and feeding in the rats that received leptin infusion while fasting. In contrast, rats infused with PBS had a marked increase in food intake, rapid weight gain, and elevated plasma leptin levels within 24 -48 h of initiation of refeeding.
Effects on hypothalamic neuropeptide mRNA expression. Arcuate hypothalamic NPY mRNA increased by 40 -50% in response to fasting (Figs. 6, A-C; and 7 ). There was a marked increase in NPY mRNA in the dorsolateral region of the arcuate hypothalamic nucleus (Fig. 6B) . POMC (Figs. 6, D-F; and 7) and CART mRNA (Figs. 6, G-H; and 7) levels decreased by 25% (P Ͻ 0.05) in the arcuate hypothalamic nucleus. In addition, CART mRNA levels were reduced significantly, by 20%, in the dorsomedial hypothalamic nucleus in response to fasting (data not shown). POMC and CART mRNA levels in the retrochiasmatic area were not altered by fasting or maintenance of leptin within physiologic levels during fasting (data not shown). Leptin infusion prevented the rise in arcuate hypothalamic NPY mRNA expression (Figs. 6, A-C; and 7) and the fall in POMC (Figs. 6, D-F; and 7) and CART mRNA (Figs. 6, G-H; and 7) expression during fasting. CRH mRNA expression in the paraventricular hypothalamic nucleus was not affected by starvation or leptin infusion (Fig. 7) .
Discussion
This study provides further insight into the complex interrelationship between leptin, other metabolic hormones, and hypothalamic target neurons expressing neuropeptides involved in the regulation of feeding behavior and autonomic and neuroendocrine function. Previous studies have revealed that leptin inhibits the expression of orexigenic peptides and stimulates the expression of anorexigenic peptides in the hypothalamus (2, 4, 5, 7-9). Consistent with this view, leptin decreases NPY mRNA levels in the arcuate hypothalamic nucleus of ob/ob and starved mice (2, 4, 5). Conversely, leptin increases the hypothalamic expression of putative anorexigenic peptides, e.g. POMC (precursor of ␣-MSH), CART, and CRH (2, 7-9). Although these findings have contributed toward understanding of the mechanisms underlying leptin action in the brain, such studies have not determined the specific responses of hypothalamic targets across the dose range for leptin. Specifically, it is not known whether the actions of leptin during the transition from the starved to fed state are sensed by similar groups of neurons, as when its levels are further elevated by overfeeding. Here, we show, for the first time, that leptin has distinct effects on the expression of hypothalamic neuropeptides, regulation of hormone levels, and feeding behavior within these two phases of the leptin dose-response curve.
To study the response to leptin at the low end of the dose-response curve, leptin was administered, by constant sc infusion, to fasted rats, with the goal of maintaining plasma leptin at levels observed in ad lib chow-fed rats, and the expression of various hypothalamic neuropeptides implicated in feeding behavior was examined. Maintaining plasma leptin prevented the increase in NPY mRNA levels and the fall in POMC and CART mRNAs in the arcuate hypothalamic nucleus that are seen with fasting. The design of this study, in which leptin infusion prevented the fall in plasma leptin without producing supraphysiologic levels, allows us to conclude that the fall of leptin with fasting is sufficient to produce these effects. In contrast to the fasting paradigm, constant sc leptin infusion, which increased plasma leptin in ad lib-fed rats to levels observed with overfeeding or moderate obesity, suppressed NPY mRNA below that of the fed state but did not affect the expression of putative anorexigenic peptides. Thus, whereas increased leptin levels produced a dose-related decrease in NPY mRNA expression in the arcuate hypothalamic nucleus, POMC and CART mRNA levels were not affected. These are the first results, to our knowledge, of the capacity of leptin-responsive hypothalamic neurons to respond to a modest rise in leptin levels above the normal fed range.
Studies have reported that CRH mRNA expression is reduced or unchanged in the paraventricular hypothalamic nucleus as a result of fasting or food restriction (15-17).
Furthermore, CRH has been proposed as a potential central mediator of the anorectic action of leptin, along with ␣-MSH and CART (2, (7) (8) (9) . However, in the present study, we did not detect any change in CRH mRNA levels in the paraventricular hypothalamic nucleus in response to fasting or a rise in leptin.
Based on the regulation of hypothalamic neuropeptides and feeding behavior by leptin in the fasted state, we speculate that low leptin levels stimulate hyperphagia and weight gain in the postfast period, at least in part, by increasing NPY levels and decreasing the expression of the anorexigenic peptides ␣-MSH and CART in the arcuate hypothalamic nucleus. During the postfast period, leptin levels would be expected to increase as a result of hyperphagia, leading to a decrease in NPY levels, an increase in ␣-MSH and CART levels, and a reduction in food intake and stabilization of body weight at the prefast level. At the other end of the dose-response curve, mild chronic hyperleptinemia resulted in a dose-related decrease in body weight gain and food intake in ad lib-fed rats. It is likely that the reduction in nocturnal feeding and weight gain in ad lib-fed rats in response to chronic elevation in leptin is mediated, at least in part, by a fall in NPY mRNA levels. The lack of effect of chronic leptin elevation on POMC, CART, and CRH mRNA levels suggests that hypothalamic neurons expressing these putative anorexigenic peptides are not as sensitive, as NPY neurons, to a chronic rise in leptin in the fed state, at least at the level of mRNA expression. However, because NPY-deficient mice respond normally to inhibition of food intake by leptin (18) , other targets must exist. The inhibitory action of rising leptin levels on feeding may be mediated by peptides, such as agouti-related peptide, which we did not assess in this study (2, 19) , or by as-yet-undefined targets in the hypothalamus or other brain regions. In addition, actions of leptin may involve effects apart from changes in neuropeptide gene expression.
Mammals have the ability to match caloric intake to expenditure, such that overfeeding triggers a compensatory decrease in food intake and weight loss to restore energy balance. Involuntary overfeeding by gastric infusion has been shown to suppress voluntary food intake and body weight in rats (16, 20) . An increase in hypothalamic CRH and POMC mRNA levels, during the period of overfeeding, has been proposed to mediate the ensuing hypophagic response (16, 20) . In contrast to CRH and POMC, hypothalamic NPY mRNA expression was not altered by overfeeding (16) . It has been suggested that the aforementioned regulation of hypothalamic neuropeptide expression in the overfed state may be mediated by a rise in leptin; however, leptin was not measured in that study (16) . Unlike the effect of overfeeding, chronic leptin elevation in the current study decreased NPY mRNA without affecting CRH and POMC mRNA levels. The hypothalamic neural responses to chronic leptin infusion in the current study might differ from the response to involuntary overfeeding as a result of several important distinctions between these two states. For example, the state of afferent signals from the gut is different in overfeeding vs. leptin administration.
The observation that a modest rise in plasma leptin, within the dose range associated with mild to moderate obesity, has marked inhibitory effects on food intake and body weight gain in ad lib chow-fed rats is in agreement with a study by Halaas et al. (21) . In that study, a 1.4-to 5-fold increase in plasma leptin, from constant sc leptin infusion, decreased body weight by 5-15% and increased energy expenditure in ad lib-fed mice. Although we did not measure the latter in our experiment, it is likely that the reduction in weight gain in rats was partly attributable to increased thermogenesis (1-3) . These responses to leptin infusion contrast with earlier reports that wild-type rodents have decreased sensitivity to peripheral leptin injection (22) (23) (24) . It is likely that the bioavailabilty of leptin is suboptimal when administered by bolus injection.
The ability of a chronic mild elevation in plasma leptin, from sc infusion, to exert marked effects on feeding and body weight contrasts with the failure of much greater increases in endogenous leptin levels to decrease food intake and adiposity in diet-induced obesity (25) (26) (27) . Although hyperleptinemia in diet-induced obesity is thought to represent a state of leptin resistance, the mechanisms underlying the lack of response to rising endogenous leptin levels are not known (1) (2) (3) . A possible explanation for the lack of response to rising endogenous leptin levels, compared with recombinant leptin, is the difference in potency between the two proteins. It is also possible that alterations in leptin transport into the brain or inhibition of leptin action by molecules such as SOCS-3 (a member of the suppressor of cytokine signaling family) may alter the sensitivity to endogenous leptin (1, 2, 28) . Further studies will be required to understand the molecular mechanisms underlying the apparent failure of negative feedback regulation by high leptin levels in diet-induced obesity.
Effects of leptin at the low end of the dose-response curve on the neuroendocrine axis were studied by administering leptin by constant sc infusion, to increase plasma levels from low (fasted) to the normal fed range. In agreement with a previous study in which leptin was administered by bolus ip injection, leptin infusion prevented the fall in T 4 and testosterone but did not alter insulin levels (4, 29) . The observation that maintenance of plasma leptin within the physiologic range prevents the fall in T 4 and testosterone further extends the view that the fall in leptin is the critical mediator of the adaptation of thyroid and gonadal axes to fasting (1, 4, 29) . We have previously reported that suppression on the thyroid axis, by falling leptin levels during fasting, is mediated by decreased expression of TRH (29) . Moreover, ablation of the arcuate hypothalamic nucleus with monosodium glutamate prevents the leptin-mediated regulation of thyroid hormones during fasting (30) . Because NPY and POMC neurons in the arcuate hypothalamic nucleus are direct leptin targets and, in turn, regulate the hypophysiotropic TRH axis, it is likely that the effect of leptin on the thyroid axis is mediated, at least in part, through action on these neurons (30) . As with the thyroid axis, results in rodents and nonhuman primates suggest that the suppression of reproductive hormones during fasting is mediated by central action of leptin in the pituitary or the brain (31, 32) .
The rise in leptin from low to normal levels did not prevent activation of the hypothalamic-pituitary-adrenal (HPA) axis, as was observed in response to ip leptin injection (4) . Studies have shown that leptin blunts the activation of the HPA axis during fasting and in response to restraint stress or ACTH stimulation (4, 33) . Moreover, leptin directly inhibits glucocorticoid secretion by adrenal cortical cells (34, 35) . However, supraphysiologic doses of leptin were used in most of these studies. The failure of maintenance of plasma leptin levels, within the near-physiologic range, to prevent the fasting-induced rise in corticosterone in the present study suggests that the hypophysiotropic CRH neuron is less sensitive to changing leptin levels. Whether achievement of leptin levels slightly higher than those attained here would prevent the activation of the HPA axis will require further study.
In contrast with fasted rats, chronic elevation of leptin above the ad lib-fed range did not affect T 4 and testosterone levels. Circadian rhythms of leptin and glucocorticoids are temporally related to the feeding cycle in rodents and humans (4, 13, 36, 37) . In ad lib-fed rats, leptin expression peaks several hours after maximal feeding in the dark cycle, and the nadir of leptin precedes the nocturnal rise in corticosterone (4, 38) . Chronic leptin infusion prevented the normal fall in leptin in ad lib-fed rats and, therefore, enabled us to determine whether the corticosterone rhythm and light-dark feeding patterns may be regulated by leptin. Interestingly, chronic elevation of leptin prevented the nocturnal rise in corticosterone and reduced nocturnal feeding; however, maximum food intake still occurred during the dark cycle. These findings suggest that diurnal leptin variations may influence the diurnal corticosterone rhythm; however, it is unlikely to be the primary drive for the feeding cycle under ad lib-fed conditions.
Taken together, the differential effects of leptin on neuropeptide expression and hormone levels under ad lib-fed and fasted conditions suggest that there are distinct thresholds for leptin action on hypothalamic neuronal targets. This view is supported by a recent study by Ioffe et al. (39) , in which expression of different levels of leptin from the prenatal period had variable effects on feeding, thermogenesis, adiposity, and neuroendocrine function in postnatal ob/ob mice. For example, expression of one half of the mean plasma leptin levels observed in wild-type mice fully corrected neuroendocrine abnormalities, including infertility, partially blunted hyperphagia, and weight gain, but it did not amelioriate thermoregulatory abnormalities in transgenic ob/ob mice. On the basis of these and other data, Friedman and colleagues (2, 39) proposed that distinct neural targets responded to low vs. high leptin levels. NPY was proposed to mediate the effects of low leptin, whereas anorexigenic peptides (such as POMC and CART) were proposed to respond to leptin levels above the normal range (2) . In contrast, our results show that NPY is responsive to both low and high leptin, whereas POMC and CART respond to low leptin and not to a chronic rise in leptin levels.
Our results provide new insights into the role of leptin as a hormone signal for both the adaptation to fasting, as well as caloric excess. Because starvation is a greater threat than food excess, the greater sensitivity of hypothalamic neural mechanisms to a reduction in leptin, as adipose energy stores decline [as evidenced by both an increase in the expression of NPY (orexigenic) and a decrease in the expression of POMC and CART (anorexigenic)] may be necessary to trigger responses aimed at energy conservation and promoting food intake. The dual role of leptin in energy homeostasis, i.e. responses to starvation and overfeeding, is likely to involve differential dose-responses on hypothalamic neurons expressing peptides involved in the regulation of feeding behavior, thermogenesis, and neuroendocrine function.
